as 03-28-2025 4:00pm EST
Founded: | 1898 | Country: | United States |
Employees: | N/A | City: | CHICAGO |
Market Cap: | N/A | IPO Year: | 2002 |
Target Price: | $238.69 | AVG Volume (30 days): | 2.9M |
Analyst Decision: | Hold | Number of Analysts: | 16 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 9.67 | EPS Growth: | 9.14 |
52 Week Low/High: | $190.70 - $267.91 | Next Earning Date: | 04-23-2025 |
Revenue: | $6,120,300,000 | Revenue Growth: | 9.90% |
Revenue Growth (this year): | 4.59% | Revenue Growth (next year): | 4.62% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Lucas Deborah J | CME | Director | Mar 14 '25 | Sell | $256.95 | 1,500 | $385,425.00 | 3,356 | |
SIEGEL HOWARD J | CME | Director | Mar 13 '25 | Sell | $260.00 | 10,000 | $2,600,000.00 | 21,873 | |
DUFFY TERRENCE A | CME | Chairman and CEO | Mar 11 '25 | Sell | $259.18 | 30,000 | $7,775,400.00 | 53,205 | |
Sprague Suzanne | CME | COO & Global Head of Clearing | Mar 3 '25 | Sell | $256.83 | 1,500 | $385,249.35 | 8,036 | |
Piell Hilda Harris | CME | Sr MD & Chief HR Officer | Feb 27 '25 | Sell | $250.47 | 3,984 | $997,852.56 | 27,046 | |
Vroman Ken | CME | Chief Transformation Officer | Feb 13 '25 | Sell | $250.00 | 5,066 | $1,266,500.00 | 16,715 | |
Winkler Julie | CME | Sr MD Chief Commercial Officer | Feb 13 '25 | Sell | $249.17 | 11,592 | $2,888,378.64 | 21,885 |
CME Breaking Stock News: Dive into CME Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Simply Wall St.
4 days ago
Bloomberg
4 days ago
PR Newswire
4 days ago
Yahoo Finance Video
5 days ago
Motley Fool
5 days ago
Bloomberg
9 days ago
PR Newswire
9 days ago
The information presented on this page, "CME CME Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.